Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax RateTax Rate
Others
Ratios

Iveda Solutions (IVDA) Shares Outstanding (Weighted Average) (2016 - 2024)

Iveda Solutions has reported Shares Outstanding (Weighted Average) over the past 12 years, most recently at $2.1 million for Q3 2024.

  • Quarterly results put Shares Outstanding (Weighted Average) at $2.1 million for Q3 2024, up 2.52% from a year ago — trailing twelve months through Sep 2024 was $2.1 million (up 2.52% YoY), and the annual figure for FY2022 was $12.8 million, up 43.69%.
  • Shares Outstanding (Weighted Average) for Q3 2024 was $2.1 million at Iveda Solutions, up from $2.0 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for IVDA hit a ceiling of $51.7 million in Q4 2020 and a floor of $2.0 million in Q3 2023.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $10.7 million (2022), compared with a mean of $14.8 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): skyrocketed 60.14% in 2023 and later plummeted 87.26% in 2024.
  • Iveda Solutions' Shares Outstanding (Weighted Average) stood at $51.7 million in 2020, then tumbled by 82.71% to $8.9 million in 2021, then soared by 43.69% to $12.8 million in 2022, then plummeted by 84.39% to $2.0 million in 2023, then increased by 2.52% to $2.1 million in 2024.
  • The last three reported values for Shares Outstanding (Weighted Average) were $2.1 million (Q3 2024), $2.0 million (Q2 2024), and $16.2 million (Q1 2024) per Business Quant data.